Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift
Cardiac Failure Review · 17.07.2025 · 11
DOI: 10.15420/cfr.2024.33 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiac Failure Review, online erschienen am 17.07.2025. Verfasst von Giorgia Panichella und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence Florence, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) and cardiac amyloidosis (CA) are significant clinical challenges, with evolving epidemiological patterns reshaping the understanding of these conditions. Traditionally linked with HF with preserved ejection fraction, CA is increasingly recognised for its specific characteristics, including a considerable subset of patients presenting with reduced left ventricular ejection fraction. This review explores how the neurohormonal activation observed in CA impacts on disease progression and management strategies. Historically, neurohormonal antagonists were considered contraindicated in CA owing to concerns about autonomic dysfunction and chronotropic incompetence. However, recent evidence suggests a paradigm shift, indicating that such agents may offer therapeutic benefits even in these patients. By examining these developments, this review provides a comprehensive overview of current therapeutic approaches, the role of neurohormonal modulation and the need for personalised care strategies to address the complexities of HF in the context of CA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental and Clinical Medicine, University of Florence Florence, Italy.
- Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna Pisa, Italy.
- Fondazione Gabriele Monasterio Pisa, Italy.
ORCID-Profile: Giorgia Panichella, Alberto Aimo, Vincenzo Castiglione, Giuseppe Vergaro, Michele Emdin
Zitieren
APA
Panichella, G., Aimo, A., Castiglione, V., Vergaro, G., & Emdin, M. (2025). Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift. Cardiac Failure Review, 11. https://doi.org/10.15420/cfr.2024.33
Vancouver
Panichella G, Aimo A, Castiglione V, Vergaro G, Emdin M. Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift. Cardiac Failure Review. 2025;11. doi:10.15420/cfr.2024.33
BibTeX
@article{Panichella2025,
author = {Panichella, Giorgia and Aimo, Alberto and Castiglione, Vincenzo and Vergaro, Giuseppe and Emdin, Michele},
title = {Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift},
journal = {Cardiac Failure Review},
year = {2025},
volume = {11},
doi = {10.15420/cfr.2024.33}
}
EUVIMED